Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $25.77, with a market capitalization of 147.53B. The stock trades at a price-to-earnings (P/E) ratio of 19.79 and offers a dividend yield of 6.7%.
On 2026-05-13, Pfizer(PFE) stock traded between a low of $25.74 and a high of $26.09. Shares are currently priced at $25.77, which is +0.1% above the low and -1.2% below the high.
The Pfizer(PFE)'s current trading volume is 26.82M, compared to an average daily volume of 38.86M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
PFE News
Pfizer (NYSE:PFE) and Arvinas have granted global development and commercialization rights for VEPPANU, the first FDA-approved oral PROTAC for advanced or metas...
After Rigel Pharmaceuticals (RIGL) announced it has entered into an exclusive global licensing agreement with Pfizer (PFE) and Arvinas (ARVN) for Veppanu for th...
Key Points Pfizer's financial results have been subpar in recent years. The company's newer products are starting to come into their own. The drugmaker's pip...
Analyst ratings
50%
of 30 ratingsMore PFE News
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) on Tuesday said it has entered into a global license agreement with Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE) to...
Key Points Pfizer generates nearly $60 billion in annual revenue. The biggest risks facing Pfizer are upcoming patent cliffs, when drugs come off patent. Pfi...
Key Points Pfizer's revenue rose last quarter, but profits were down by 9%. Based on its latest numbers, the company's payout ratio is now north of 91%. Acqu...
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? By David Moadel Published May 11, 10:53AM EDT Quick Read Moder...
Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the November 20th expiration. One of the key inputs that goes into the price an o...
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . For a retirement-focused investor, on...
In early May 2026, Pfizer reported first-quarter revenue of US$14.45 billion, up from US$13.72 billion a year earlier, while net income eased to US$2.69 billion...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.